SYNOVUS FINANCIAL CORP - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 164 filers reported holding ANIKA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 3.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
SYNOVUS FINANCIAL CORP ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$28,000
+33.3%
7410.0%0.00%
Q1 2020$21,000
-44.7%
7410.0%0.00%
-100.0%
Q4 2019$38,000
-7.3%
7410.0%0.00%0.0%
Q3 2019$41,000
+36.7%
7410.0%0.00%
Q2 2019$30,000
+36.4%
7410.0%0.00%
Q1 2019$22,000
-53.2%
741
-46.7%
0.00%
-100.0%
Q4 2018$47,000
-32.9%
1,389
-16.3%
0.00%0.0%
Q3 2018$70,000
+268.4%
1,660
+190.7%
0.00%
Q2 2018$19,000
-32.1%
5710.0%0.00%
Q1 2018$28,0005710.00%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
HealthInvest Partners AB 490,331$21,928,00010.27%
CAPITAL MANAGEMENT CORP /VA 211,660$9,465,0003.66%
AMI ASSET MANAGEMENT CORP 336,791$15,061,0001.03%
Baltimore-Washington Financial Advisors, Inc. 68,785$3,076,0000.93%
Portolan Capital Management 130,939$5,856,0000.78%
Kalos Management, Inc. 19,254$861,0000.72%
DIKER MANAGEMENT LLC 32,965$1,474,0000.56%
THOMPSON SIEGEL & WALMSLEY LLC 1,526,244$68,253,0000.56%
NEW AMSTERDAM PARTNERS LLC/NY 108,260$4,841,0000.51%
Boston Trust Walden Corp 493,780$22,082,0000.38%
View complete list of ANIKA THERAPEUTICS INC shareholders